NVO Stock Analysis
US stocks · market data · technical indicators
Formula: fundamentals (40%) + technical indicators (30%) + market sentiment (30%)
Score range 0–100; a higher score indicates a stronger buy signal
Market Status
BuyFundamentals (US)
Market Insight
The composite score points to a strong buy signal (75/100), with several technical and fundamental indicators in positive territory. A P/E of 10.52x is relatively low, which may point to undervaluation. Return on equity of 59.82% indicates solid profitability. The target price implies roughly 25.00% upside.
This analysis is for reference only and does not constitute investment advice. Investing carries risk; educational content only.
NVO - Novo Nordisk A/S
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $78.49B | $96.82B | $79.14B | $74.98B | $76.86B |
| Gross profit | $61.39B | $83.22B | $64.00B | $57.07B | $64.01B |
| Operating income | $27.06B | $59.62B | $31.74B | $23.68B | $33.45B |
| Net income | $20.99B | $48.56B | $26.89B | $20.01B | $26.50B |
| Basic EPS | 4.74 | 10.93 | 6.06 | 4.50 | 5.96 |
| Diluted EPS | 4.74 | 10.91 | 6.04 | 4.50 | 5.96 |
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-11-04 | 5.11 | Not reported | — |
| 2026-08-04 | 4.98 | 6.18 | +24.01% |
| 2026-05-05 | 6.96 | 6.63 | -4.75% |
| 2026-02-03 | 5.90 | 6.04 | +2.34% |
| 2025-11-05 | 4.24 | 4.50 | +6.05% |
| 2025-08-06 | 6.00 | 5.96 | -0.74% |
| 2025-05-07 | 6.07 | 6.53 | +7.51% |
| 2025-02-04 | 5.97 | 6.34 | +6.15% |
| 2024-11-06 | 5.92 | 6.12 | +3.44% |
| 2024-08-07 | 4.91 | 4.49 | -8.61% |
| 2024-05-02 | 5.42 | 5.68 | +4.87% |
| 2024-01-31 | 4.45 | 4.91 | +10.34% |
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| BlackRock Inc. | 2024-06-30 | $779.7M | 0.02% |
| STATE STREET CORP | 2026-06-30 | $284.6M | 0.01% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $145.4M | 0.20% |
| CITADEL ADVISORS LLC | 2026-06-30 | $65.5M | 0.01% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $757.5K | 0.00% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
- 2026-08-17$0.4078
- 2026-03-30$0.8737
- 2025-08-18$0.4116
- 2025-03-31$0.8191